Viren M - Search Results

1

Economic hardship and suicide mortality in Finland, 1875-2010.

Korhonen M, Puhakka M, Viren M. Korhonen M, et al. Among authors: viren m. Eur J Health Econ. 2016 Mar;17(2):129-37. doi: 10.1007/s10198-014-0658-5. Epub 2014 Dec 2. Eur J Health Econ. 2016. PMID: 25446657

2

Attitudes towards euthanasia among physicians, nurses and the general public in Finland.

Ryynänen OP, Myllykangas M, Viren M, Heino H. Ryynänen OP, et al. Among authors: viren m. Public Health. 2002 Nov;116(6):322-31. doi: 10.1038/sj.ph.1900875. Public Health. 2002. PMID: 12407471

3

[An unexplained cancer disease and bone metastases].

Keski-Nisula L, Katila ML, Virén M, Kataja V, Katila T. Keski-Nisula L, et al. Among authors: viren m. Duodecim. 1998;114(8):777-81. Duodecim. 1998. PMID: 11524794 Finnish. No abstract available.

4

Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.

Pirinen R, Hirvikoski P, Böhm J, Kellokoski J, Moisio K, Virén M, Johansson R, Hollmén S, Kosma VM. Pirinen R, et al. Among authors: viren m. Hum Pathol. 2000 Sep;31(9):1088-95. doi: 10.1053/hupa.2000.16277. Hum Pathol. 2000. PMID: 11014576

5

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.

Isokangas OP, Knuuttila A, Halme M, Mäntylä M, Lindström I, Nikkanen V, Viren M, Joensuu H, Mattson K. Isokangas OP, et al. Among authors: viren m. Ann Oncol. 1999 Sep;10(9):1059-63. doi: 10.1023/a:1008305017829. Ann Oncol. 1999. PMID: 10572603 Free article. Clinical Trial.

6

Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung.

Pirinen RT, Tammi RH, Tammi MI, Pääkkö PK, Parkkinen JJ, Agren UM, Johansson RT, Viren MM, Törmänen U, Soini YM, Kosma VM. Pirinen RT, et al. Among authors: viren mm. Int J Cancer. 1998 Jun 19;79(3):251-5. doi: 10.1002/(sici)1097-0215(19980619)79:3<251::aid-ijc7>3.0.co;2-o. Int J Cancer. 1998. PMID: 9645346

7

Flow cytometric analysis of tumor DNA profile related to response to treatment and survival in small-cell lung cancer.

Virén MM, Ojala AT, Kataja VV, Mattila JJ, Koivisto PA, Nikkanen VT. Virén MM, et al. Med Oncol. 1997 Mar;14(1):35-8. doi: 10.1007/BF02990943. Med Oncol. 1997. PMID: 9232609

8

Carboplatin and etoposide in extensive small cell lung cancer.

Viren M, Liippo K, Ojala A, Helle L, Hinkka S, Huovinen R, Jakobsson M, Järvinen M, Paloheimo S, Salmi R, et al. Viren M, et al. Acta Oncol. 1994;33(8):921-4. doi: 10.3109/02841869409098457. Acta Oncol. 1994. PMID: 7818926 Clinical Trial.

9

Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.

Virén M, Liippo K, Ojala A, Helle L, Jakobson M, Järvinen M, Paloheimo S, Salomaa ER, Salmi R, Nikkanen V. Virén M, et al. Acta Oncol. 1992;31(7):761-5. doi: 10.3109/02841869209083867. Acta Oncol. 1992. PMID: 1335738 Clinical Trial.

10

Aclarubicin in the treatment of advanced gastrointestinal adenocarcinoma.

Elomaa I, Salmo M, Roos L, Helle L, Korpela M, Numminen S, Virén M, Allonen H. Elomaa I, et al. Among authors: viren m. Acta Oncol. 1990;29(5):636-7. doi: 10.3109/02841869009090066. Acta Oncol. 1990. PMID: 2206579 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters